Page 4 - Iological Marker News Today

"Tape strips can provide important clues to when and which drugs to use in HS in patients with both early and late disease, which can change clinical practice."

Cross-sectional study with a diverse cohort revealed no effect modification associated with Hispanic ethnicity.

'Use of biomarkers is no longer considered experimental and should be an integral part of IBD care and monitoring.'

Although predictive tools to identify those at risk of disease progression are in their infancy, the development of such tools is crucial for improving patient outcomes.

Researchers have pinpointed a potential common link to the varying symptoms of long COVID and specific testing could solve the mystery.

The antiamyloid monoclonal antibody gantenerumab led to a lower amyloid plaque burden but no clear cognitive benefit in early Alzheimers disease in twin pivotal trials.

After years of working with the National Cancer Institute, W. Kimryn Rathmell, MD, PhD, gets the call to run the institute.

An experimental assay detects epigenetic features within the unique patterns and sizes of cell-free DNA found in blood, but is it better than clinical diagnostics?

A study of midlife women found an association between higher posttraumatic stress disorder symptoms and worse cardiovascular and neurocognitive health.

Patients with darker skin types tend to have larger nodules that might vary in shape relative to lighter skin types, according to Shawn Kwatra, MD.